TSE:3407Chemicals
Will AgeTech and PetTech Advances Redefine Asahi Kasei's Healthcare Strategy for TSE:3407 Investors?
Asahi Kasei recently announced several product advancements, including plans to showcase new health and pet monitoring sensing technologies at CES 2026 and confirmation of Nefecon’s (marketed as TARPEYO in the U.S.) inclusion in the 2025 global KDIGO guidelines for treating IgA nephropathy.
These initiatives underscore Asahi Kasei’s effort to address demographic trends in health and wellness, with innovative solutions targeting both aging populations and the growing market for pet health...